CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell William Jenkins, Shuai Li, Ruben Dries, Kathleen B. Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, Amir Reza Aref, Elena V. Ivanova, Cloud Peter Paweletz, Michaela Bowden, Chensheng Willa Zhou, Grit Sophie Herter-Sprie, Jessica A. Sorrentino, John Bisi, Patrick Hall Lizotte, Ashley A. Merlino, Max M. Quinn, Lauren E. Bufe, Annan Yang, Yanxi Zhang, Hua Zhang, Peng Gao, and 22 more

View at source ↗Article770 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1158/2159-8290.cd-17-0915
Published
Nov 3, 2017
Venue
Cancer Discovery
DOI
10.1158/2159-8290.cd-17-0915
PubMed
29101163
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics